The Foundation supports research that can lead to the creation of better Parkinson's treatments. Here you can search previously awarded grants by keyword, program name, researcher name, institution or organization name and/or year.
FUNDED GRANTS ( 4)
LRRK2 Cohort Working Group, 2012
Two groups have reported a possible association between carrying a LRRK2 mutation and non-skin cancers. In order to determine whether this finding is present in a larger group, or whether specific factors in those populations account for the higher rate of cancer, a larger study from more locations, and with a larger group of Parkinson's subjects and their family...
Researchers: Rachel Saunders-Pullman, MD, MPH, MS
Neuropathological studies have been vital in Parkinson’s disease (PD) research. The gold-standard diagnosis of PD is confirmed at autopsy. In addition, information on key proteins and cellular processes involved in PD is obtained from autopsy neuropathological samples. Here, we form an international collaborative group committed to uniform collection, storage and processing o...
We are examining a Symptoms & Side Effects family members of LRRK2-PD patients looking for clinical features indicating differences between mutation carriers and non-carriers. Changes in metabolic patterns in blood and spinal fluid between LRRK2 patients and a Symptoms & Side Effects family members may help us find the crucial biochemical abnormality in brain which starts th...
Postural Instability and Gait Disturbances, 2009
The role of White Matter Pathology in the development of the Postural Instability and Gait Disturbance (PIGD) type of Parkinson's disease (PD)-1
It is not clear why a subset of patients with Parkinson's disease develop postural instability and gait disturbances (PIGD), while others do not. White matter (WM) changes that may sometimes reflect subtle alterations in brain structure and function are known to contribute to PIGD-like symptoms in older adults and in other patient groups. The relationship between WM changes a...
Researchers: Jeffrey M. Hausdorff, PhD